This review highlights the biological activities and pharmacological potential of metabolites in Porcelia macrocarpa, indicating diverse applications in various fields.
Porcelia macrocarpa is a Brazilian plant species belonging to the Annonaceae family. To date, more than 190 compounds have been identified and/or isolated from this species, with terpenoids comprising the majority (62%). Alkaloids represent the second most abundant class (11%), followed by steroids (4%), acetogenins (4%), fatty acids (4%), arylpropanoids (3%), and flavonoids (1%). These metabolites exhibit a wide range of biological activities, including antibacterial, antifungal, antiviral, cytotoxic, anti‐inflammatory, antiparasitic, and antioxidant effects. This review highlights the remarkable chemical profile of P. macrocarpa and the pharmacological potential of the metabolites identified in this species, offering valuable insights into its possible applications and encouraging further research across multiple scientific and medical fields.
No takes yet. Share an insight, caveat, or question.
Thevenard et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: